Arrowhead Research reported $-48429000 in Pre-Tax Profit for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -98.98M 8.5M
Anika Therapeutics ANIK:US $ -8.15M 1.34M
Arrowhead Research ARWR:US $ -48.43M 34.82M
Cerulean Pharma CERU:US $ -7.58M 0.46M
Dicerna Pharmaceuticals DRNA:US $ -21.85M 9.97M
Intercept Pharmaceuticals ICPT:US $ -53.09M 10.19M
Ligand Pharmaceuticals LGND:US $ 33.04M 10.67M
Mirati Therapeutics MRTX:US $ -87.34M 4.48M
Moderna Inc MRNA:US -232772000 116.21M
Nektar Therapeutics NKTR:US $ -108.56M 28.71M
Opko Health OPK:US $ 45.94M 25.34M
Sarepta Therapeutics SRPT:US $ -196.4M 45.6M
Spectrum Pharmaceuticals SPPI:US $ -48.51M 16.29M
Tg Therapeutics TGTX:US $ -87.16M 34.28M
Ultragenyx Pharmaceutical RARE:US $ 55.16M 123.69M
Vertex Pharmaceuticals VRTX:US $ 858.3M 6.27M
YTE INCY:US $ 222.92M 156.76M